Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial for Effectiveness and Safety Evaluation of Hemodiafilter

NCT06454981 is registered in ClinicalTrials.gov with Hangzhou Kaiyuan Suixi Medical Technology Co., Ltd as lead sponsor.

NCT NCT06454981
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06454981 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial for Effectiveness and Safety Evaluation of Hemodiafilter
Lead sponsor
Hangzhou Kaiyuan Suixi Medical Technology Co., Ltd
Phase
Not applicable
Overall status
Completed
Start date
July 23, 2021
Completion date
February 12, 2022
Enrollment
160 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal failure chronic